Home › Funds › HighVista Strategies LLC › GPCR
HighVista Strategies LLC position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
HighVista Strategies LLC reported holding 170,193 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.3M, representing 1.40% of its reported portfolio and ranking #17 among its reported holdings. HighVista Strategies LLC has disclosed GPCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How HighVista Strategies LLC's GPCR position evolved
HighVista Strategies LLC first disclosed a stake in GPCR in Q3 2023 at 74,832 shares (US$3.8M). The position peaked in Q4 2025 at 193,001 shares, worth US$13.4M. Across 13 filings, HighVista Strategies LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 170,193 shares valued at US$5.3M — an increase of 39,409 shares quarter over quarter.. Notable position changes include a 50% trim in Q1 2024 (shares fell 8% over the following quarter), a 393% increase in Q2 2025 (shares rose 35% over the following quarter), a 173% increase in Q3 2025 (shares rose 148% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 74.83K | $3.77M | New |
| Q4 2023 | 74.83K | $3.05M | Hold |
| Q1 2024 | 37.44K | $1.60M | Reduce |
| Q2 2024 | 35.13K | $1.38M | Reduce |
| Q3 2024 | 31.72K | $1.39M | Reduce |
| Q4 2024 | 17.56K | $476.25K | Reduce |
| Q1 2025 | 17.56K | $303.98K | Hold |
| Q2 2025 | 86.62K | $1.80M | Add |
| Q3 2025 | 236.24K | $6.61M | Add |
| Q4 2025 | 193.00K | $13.42M | Reduce |
| Q1 2026 | 123.91K | $5.97M | Reduce |
| Q2 2026 | 130.78K | $7.02M | Add |
| Q3 2026 | 170.19K | $5.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Siren, L.L.C. 872.97K sh · $27.30M · Q3 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
- Parkman Healthcare Partners LLC 485.66K sh · $26.07M · Q2 2026
More on HighVista Strategies LLC
FAQ
How long has HighVista Strategies LLC held GPCR?
HighVista Strategies LLC has disclosed GPCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is HighVista Strategies LLC's current position in GPCR?
As of Q3 2026, HighVista Strategies LLC holds 170.19K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $5.32M, representing 1.40% of its reported portfolio and ranking #17.
Has HighVista Strategies LLC been buying or selling GPCR?
In the latest 13F filing (Q3 2026), HighVista Strategies LLC increased its position in GPCR. The position peaked in Q4 2025 at 193.00K shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.